THC BioMed Ships Canada’s First 10 mg Ready-to-Drink Cannabis Beverage Shot

VANCOUVER, BC – THC BioMed Intl Ltd. (“THC BioMed” or the “Company”) is pleased to announce that it is shipping its ready-to-drink Cannabis Beverage Shot, THC KISS, to British Columbia’s legal adult recreational cannabis market today. THC BioMed has also filled a second order for THC KISS to its Saskatchewan distributor.

The Province of Alberta is currently in negotiations with THC Biomed to make THC KISS available to the Alberta legal adult recreational cannabis market.


THC KISS is a brand new Cannabis Beverage Shot that promises to offer a different experience compared to edibles and beverages currently available in either the grey or legal cannabis markets.

THC KISS aims to be an alternative to smoking cannabis and was developed by THC BioMed using proprietary extraction methods invented by THC BioMed.

“We continue to receive very positive feedback on THC KISS from our consumers, with repeat orders per client increasing substantially. We are proud to bring Canadians a true alternative to smoking cannabis,” commented John Miller, President and CEO.

Each 30ml bottle of THC KISS contains 10 mg of THC.

About THC BioMed
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.